Protective Effect of Bergapten against Human Erythrocyte Hemolysis and Protein Denaturation In Vitro

被引:31
作者
Aidoo, Douglas Bosco [1 ]
Konja, Daniels [2 ]
Henneh, Isaac Tabiri [3 ]
Ekor, Martins [4 ]
机构
[1] Kwame Nkrumah Univ Sci & Technol, Fac Pharm & Pharmaceut Sci, Dept Pharmacol, Coll Hlth Sci, Kumasi, Ghana
[2] Univ Cape Coast, Sch Allied Hlth Sci, Dept Biomed Sci, Cape Coast, Ghana
[3] Univ Cape Coast, Sch Pharm & Pharmaceut Sci, Dept Pharmacotherapeut & Pharm Practice, Coll Hlth & Allied Sci, Cape Coast, Ghana
[4] Univ Cape Coast, Sch Med Sci, Dept Pharmacol, Coll Hlth & Allied Sci, Cape Coast, Ghana
关键词
ANTIINFLAMMATORY ACTIVITY; OXIDATIVE DAMAGE; EXTRACT; PHENYLHYDRAZINE; COUMARINS; AGENTS; VIVO;
D O I
10.1155/2021/1279359
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Bergapten, a furocoumarin found in many medicinal plants, is used for the management of various conditions. The present in vitro study evaluated the ability of bergapten to prevent human erythrocyte hemolysis and protein denaturation. Bergapten administered at 10, 30, and 100 mu g/ml exhibited a significant concentration-dependent protection on the erythrocyte membrane exposed to hypotonicity and heat-induced hemolysis. The concentration at which bergapten inhibited 50% of the cells from hemolysis (IC50) was determined on a dose-response curve, plotted as logarithmic (concentration) against percentage inhibition, keeping the hemolysis produced within the control group at 100%. Bergapten treatment produced an IC50 value of 7.71 +/- 0.27 mu g/ml and 4.23 +/- 0.42 mu g/ml for hypotonicity and heat-induced hemolysis, respectively. Diclofenac sodium at similar concentrations produced an IC50 value of 12.22 +/- 0.30 mu g/ml and 9.44 +/- 0.23 mu g/ml in the hypotonicity and heat-induced hemolysis, respectively. The ability of bergapten to inhibit protein denaturation was studied as part of an investigation on its mechanism of action. The results showed a significant concentration-dependent reduction in protein denaturation. When administered at 10, 30, and 100 mu g/ml, bergapten produced a concentration-dependent reduction in albumin denaturation. Bergapten inhibited protein denaturation with IC50 values of 5.34 +/- 0.30 mu g/ml and 12.18 +/- 0.20 mu g/ml in the heat-treated egg albumin and bovine serum albumin denaturation experiments, respectively. Diclofenac sodium (10, 30, and 100 mu g/ml) exhibited a similar protection against heat-treated egg albumin and bovine serum albumin denaturation experiments with IC50 values of 8.93 +/- 0.17 mu g/ml and 12.72 +/- 0.11 mu g/ml, respectively. Taken together, data from this study show that the pharmacological properties of bergapten may in part be related to its membrane-stabilizing and antidenaturation properties.
引用
收藏
页数:7
相关论文
共 47 条
[11]  
2-L
[12]  
Duganath N., 2010, INT J PHARMA BIOSCIE, V1, P1
[13]   IRON RELEASE AND MEMBRANE DAMAGE IN ERYTHROCYTES EXPOSED TO OXIDIZING-AGENTS, PHENYLHYDRAZINE, DIVICINE AND ISOURAMIL [J].
FERRALI, M ;
SIGNORINI, C ;
CICCOLI, L ;
COMPORTI, M .
BIOCHEMICAL JOURNAL, 1992, 285 :295-301
[14]  
Foresto P, 2000, MEDICINA-BUENOS AIRE, V60, P570
[15]   Anti-inflammatory activity of Dalbergia sissoo leaves [J].
Hajare, SW ;
Chandra, S ;
Sharma, J ;
Tandan, SK ;
Lal, J ;
Telang, AG .
FITOTERAPIA, 2001, 72 (02) :131-139
[16]   Measuring reactive species and oxidative damage in vivo and in cell culture:: how should you do it and what do the results mean? [J].
Halliwell, B ;
Whiteman, M .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (02) :231-255
[17]   Methoxsalen and Bergapten Prevent Diabetes-Induced Osteoporosis by the Suppression of Osteoclastogenic Gene Expression in Mice [J].
Ham, Ju Ri ;
Choi, Ra-Yeong ;
Lee, Hae-In ;
Lee, Mi-Kyung .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06)
[18]   Protective effect of Terminalia arjuna against alcohol induced oxidative damage of rat erythrocyte membranes [J].
Hebbani, Ananda Vardhan ;
Vaddi, Damodara Reddy ;
Dd, Padma Priya ;
NCh, Varadacharyulu .
JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2021, 12 (02) :330-339
[19]  
Henneh I.T., 2018, West Sfr. J. Pharm, V29, P81
[20]   Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry [J].
Inzinger, M. ;
Heschl, B. ;
Weger, W. ;
Hofer, A. ;
Legat, F. J. ;
Gruber-Wackernagel, A. ;
Tilz, H. ;
Salmhofer, W. ;
Quehenberger, F. ;
Wolf, P. .
BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (03) :640-645